Showing 1 to 1 of 1 results
repubblica.it
🌐 85% Global Worthiness
Promising Phase 1 Results for Personalized Kidney Cancer Vaccine NeoVax
A phase 1 trial of NeoVax, a personalized cancer vaccine for kidney cancer, showed promising results in 9 patients, with all remaining disease-free after nearly three years; the vaccine induced a significant increase in T cells, highlighting its potential to prevent recurrence.
Promising Phase 1 Results for Personalized Kidney Cancer Vaccine NeoVax
A phase 1 trial of NeoVax, a personalized cancer vaccine for kidney cancer, showed promising results in 9 patients, with all remaining disease-free after nearly three years; the vaccine induced a significant increase in T cells, highlighting its potential to prevent recurrence.
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results